17
July
2015
|
00:25
Asia/Singapore

Clinical trials begin for cancer drug developed here

A team of researchers from Duke-NUS Graduate Medical School and A*STAR's Experimental Therapeutics Centre (ETC) and Drug Discovery and Development (D3) unit has developed a new cancer drug that could be a potential life-saver for people suffering from a range of cancers. It is being tested on patients here and, if successful, ETC-159, as the compound is now called, could emerge as the Republic's first cancer blockbuster.